{
    "info": {
        "nct_id": "NCT06369246",
        "official_title": "PRORAD-5 PROstate RADiation in 5 Fractions: Phase Ib Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer",
        "inclusion_criteria": "1. Pathologically (histologically or cytologically) proven diagnosis of adenocarcinoma of prostate within one year of study entry. Evaluation can happen outside of MD Anderson as long as histological confirmation takes place at MD Anderson.\n\n   1. cT1c-T3a by digital exam or imaging (AJCC 8th Ed.). No cT3b-4 by digital exam or imaging (AJCC 8th Ed.)\n   2. Gleason Grade Group 2-5 (Gleason 7, 8, 9, 10).\n   3. If Gleason Grade 2, must meet definition of unfavorable intermediate risk (at least one of the following: cT2b, PSA >10 ng/mL prior to starting androgen deprivation therapy (ADT).\n\n   If a participant is taking 5-alpha reductase inhibitors the measured PSA may be doubled).\n2. Node negative by conventional imaging.\n3. Be ≥ 18 years of age on the day of signing informed consent.\n4. Prior pharmacologic androgen ablation for prostate cancer is allowed only if the onset of androgen ablation (both LHRH agonist and oral anti-androgen) is ≤ 185 days prior to registration; Please note: baseline PSA must be obtained prior to the start of any ADT.\n5. ECOG performance status 0-2.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "1. Diagnosis of active scleroderma, lupus, or other rheumatologic disease which in the opinion of the treating radiation oncologist precludes safe RT.\n2. Prior prostatectomy, cryosurgery, or HIFU for adenocarcinoma of the prostate\n3. Prior radiotherapy to the region of the study cancer that would result in overlap of radiation fields\n4. Distant metastatic disease on conventional imaging, which by the discretion of the treating physician cannot be treated definitively.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "identified_line": {
                "line": "4. Prior pharmacologic androgen ablation for prostate cancer is allowed only if the onset of androgen ablation (both LHRH agonist and oral anti-androgen) is ≤ 185 days prior to registration; Please note: baseline PSA must be obtained prior to the start of any ADT.",
                "criterions": [
                    {
                        "exact_snippets": "Prior pharmacologic androgen ablation for prostate cancer is allowed only if the onset of androgen ablation (both LHRH agonist and oral anti-androgen) is ≤ 185 days prior to registration",
                        "criterion": "onset of androgen ablation",
                        "requirement": {
                            "requirement_type": "timing",
                            "expected_value": {
                                "operator": "<=",
                                "value": 185,
                                "unit": "days prior to registration"
                            }
                        }
                    },
                    {
                        "exact_snippets": "baseline PSA must be obtained prior to the start of any ADT",
                        "criterion": "baseline PSA",
                        "requirement": {
                            "requirement_type": "timing of measurement",
                            "expected_value": "prior to the start of any ADT"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Prior pharmacologic androgen ablation for prostate cancer is allowed only if the onset of androgen ablation (both LHRH agonist and oral anti-androgen) is ≤ 185 days prior to registration",
                        "criterion": "onset of androgen ablation",
                        "requirement": {
                            "requirement_type": "timing",
                            "expected_value": {
                                "operator": "<=",
                                "value": 185,
                                "unit": "days prior to registration"
                            }
                        }
                    },
                    {
                        "exact_snippets": "baseline PSA must be obtained prior to the start of any ADT",
                        "criterion": "baseline PSA",
                        "requirement": {
                            "requirement_type": "timing of measurement",
                            "expected_value": "prior to the start of any ADT"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "2. Node negative by conventional imaging.",
                "criterions": [
                    {
                        "exact_snippets": "Node negative by conventional imaging",
                        "criterion": "lymph node status by conventional imaging",
                        "requirement": {
                            "requirement_type": "status",
                            "expected_value": "negative"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Node negative by conventional imaging",
                        "criterion": "lymph node status by conventional imaging",
                        "requirement": {
                            "requirement_type": "status",
                            "expected_value": "negative"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "5. ECOG performance status 0-2.",
                "criterions": [
                    {
                        "exact_snippets": "ECOG performance status 0-2",
                        "criterion": "ECOG performance status",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "ECOG performance status 0-2",
                        "criterion": "ECOG performance status",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "1. cT1c-T3a by digital exam or imaging (AJCC 8th Ed.). No cT3b-4 by digital exam or imaging (AJCC 8th Ed.)",
                "criterions": [
                    {
                        "exact_snippets": "cT1c-T3a by digital exam or imaging (AJCC 8th Ed.)",
                        "criterion": "clinical tumor stage (cT)",
                        "requirement": {
                            "requirement_type": "stage",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 1,
                                        "unit": "T1c"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 3,
                                        "unit": "T3a"
                                    }
                                ]
                            }
                        }
                    },
                    {
                        "exact_snippets": "No cT3b-4 by digital exam or imaging (AJCC 8th Ed.)",
                        "criterion": "clinical tumor stage (cT)",
                        "requirement": {
                            "requirement_type": "stage",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<",
                                        "value": 3.5,
                                        "unit": "T"
                                    }
                                ]
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "cT1c-T3a by digital exam or imaging (AJCC 8th Ed.)",
                        "criterion": "clinical tumor stage (cT)",
                        "requirement": {
                            "requirement_type": "stage",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 1,
                                        "unit": "T1c"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 3,
                                        "unit": "T3a"
                                    }
                                ]
                            }
                        }
                    },
                    {
                        "exact_snippets": "No cT3b-4 by digital exam or imaging (AJCC 8th Ed.)",
                        "criterion": "clinical tumor stage (cT)",
                        "requirement": {
                            "requirement_type": "stage",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<",
                                        "value": 3.5,
                                        "unit": "T"
                                    }
                                ]
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "2. Gleason Grade Group 2-5 (Gleason 7, 8, 9, 10).",
                "criterions": [
                    {
                        "exact_snippets": "Gleason Grade Group 2-5 (Gleason 7, 8, 9, 10)",
                        "criterion": "Gleason Grade Group",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 2,
                                        "unit": ""
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 5,
                                        "unit": ""
                                    }
                                ]
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Gleason Grade Group 2-5 (Gleason 7, 8, 9, 10)",
                        "criterion": "Gleason Grade Group",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 2,
                                        "unit": ""
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 5,
                                        "unit": ""
                                    }
                                ]
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "If a participant is taking 5-alpha reductase inhibitors the measured PSA may be doubled).",
                "criterions": [
                    {
                        "exact_snippets": "participant is taking 5-alpha reductase inhibitors",
                        "criterion": "5-alpha reductase inhibitor use",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "measured PSA may be doubled",
                        "criterion": "measured PSA value",
                        "requirement": {
                            "requirement_type": "adjustment",
                            "expected_value": "may be doubled if participant is taking 5-alpha reductase inhibitors"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "participant is taking 5-alpha reductase inhibitors",
                        "criterion": "5-alpha reductase inhibitor use",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "measured PSA may be doubled",
                        "criterion": "measured PSA value",
                        "requirement": {
                            "requirement_type": "adjustment",
                            "expected_value": "may be doubled if participant is taking 5-alpha reductase inhibitors"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "Healthy volunteers allowed",
                "criterions": [
                    {
                        "exact_snippets": "Healthy volunteers allowed",
                        "criterion": "healthy volunteer status",
                        "requirement": {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Healthy volunteers allowed",
                        "criterion": "healthy volunteer status",
                        "requirement": {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "Must have minimum age of 18 Years",
                "criterions": [
                    {
                        "exact_snippets": "minimum age of 18 Years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "minimum age of 18 Years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    }
                ]
            }
        }
    ],
    "exclusion_lines": [
        {
            "identified_line": {
                "line": "2. Prior prostatectomy, cryosurgery, or HIFU for adenocarcinoma of the prostate",
                "criterions": [
                    {
                        "exact_snippets": "Prior prostatectomy ... for adenocarcinoma of the prostate",
                        "criterion": "prostatectomy for adenocarcinoma of the prostate",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Prior ... cryosurgery ... for adenocarcinoma of the prostate",
                        "criterion": "cryosurgery for adenocarcinoma of the prostate",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Prior ... HIFU for adenocarcinoma of the prostate",
                        "criterion": "HIFU for adenocarcinoma of the prostate",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Prior prostatectomy ... for adenocarcinoma of the prostate",
                        "criterion": "prostatectomy for adenocarcinoma of the prostate",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Prior ... cryosurgery ... for adenocarcinoma of the prostate",
                        "criterion": "cryosurgery for adenocarcinoma of the prostate",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Prior ... HIFU for adenocarcinoma of the prostate",
                        "criterion": "HIFU for adenocarcinoma of the prostate",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "1. Diagnosis of active scleroderma, lupus, or other rheumatologic disease which in the opinion of the treating radiation oncologist precludes safe RT.",
                "criterions": [
                    {
                        "exact_snippets": "Diagnosis of active scleroderma",
                        "criterion": "scleroderma",
                        "requirement": {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        }
                    },
                    {
                        "exact_snippets": "Diagnosis of active scleroderma",
                        "criterion": "scleroderma",
                        "requirement": {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Diagnosis of ... lupus",
                        "criterion": "lupus",
                        "requirement": {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Diagnosis of ... other rheumatologic disease",
                        "criterion": "other rheumatologic disease",
                        "requirement": {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "which in the opinion of the treating radiation oncologist precludes safe RT",
                        "criterion": "treating radiation oncologist opinion on safe RT",
                        "requirement": {
                            "requirement_type": "precludes safe RT",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Diagnosis of active scleroderma",
                                "criterion": "scleroderma",
                                "requirement": {
                                    "requirement_type": "diagnosis",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "Diagnosis of active scleroderma",
                                "criterion": "scleroderma",
                                "requirement": {
                                    "requirement_type": "activity",
                                    "expected_value": "active"
                                }
                            },
                            {
                                "exact_snippets": "which in the opinion of the treating radiation oncologist precludes safe RT",
                                "criterion": "treating radiation oncologist opinion on safe RT",
                                "requirement": {
                                    "requirement_type": "precludes safe RT",
                                    "expected_value": true
                                }
                            }
                        ]
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Diagnosis of ... lupus",
                                "criterion": "lupus",
                                "requirement": {
                                    "requirement_type": "diagnosis",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "which in the opinion of the treating radiation oncologist precludes safe RT",
                                "criterion": "treating radiation oncologist opinion on safe RT",
                                "requirement": {
                                    "requirement_type": "precludes safe RT",
                                    "expected_value": true
                                }
                            }
                        ]
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Diagnosis of ... other rheumatologic disease",
                                "criterion": "other rheumatologic disease",
                                "requirement": {
                                    "requirement_type": "diagnosis",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "which in the opinion of the treating radiation oncologist precludes safe RT",
                                "criterion": "treating radiation oncologist opinion on safe RT",
                                "requirement": {
                                    "requirement_type": "precludes safe RT",
                                    "expected_value": true
                                }
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "4. Distant metastatic disease on conventional imaging, which by the discretion of the treating physician cannot be treated definitively.",
                "criterions": [
                    {
                        "exact_snippets": "Distant metastatic disease on conventional imaging",
                        "criterion": "distant metastatic disease",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Distant metastatic disease on conventional imaging",
                        "criterion": "distant metastatic disease",
                        "requirement": {
                            "requirement_type": "detection_method",
                            "expected_value": "conventional imaging"
                        }
                    },
                    {
                        "exact_snippets": "which by the discretion of the treating physician cannot be treated definitively",
                        "criterion": "treatability of metastatic disease",
                        "requirement": {
                            "requirement_type": "treatability",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "which by the discretion of the treating physician cannot be treated definitively",
                        "criterion": "treatability of metastatic disease",
                        "requirement": {
                            "requirement_type": "assessment_by",
                            "expected_value": "discretion of the treating physician"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Distant metastatic disease on conventional imaging",
                                "criterion": "distant metastatic disease",
                                "requirement": {
                                    "requirement_type": "presence",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "Distant metastatic disease on conventional imaging",
                                "criterion": "distant metastatic disease",
                                "requirement": {
                                    "requirement_type": "detection_method",
                                    "expected_value": "conventional imaging"
                                }
                            }
                        ]
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "which by the discretion of the treating physician cannot be treated definitively",
                                "criterion": "treatability of metastatic disease",
                                "requirement": {
                                    "requirement_type": "treatability",
                                    "expected_value": false
                                }
                            },
                            {
                                "exact_snippets": "which by the discretion of the treating physician cannot be treated definitively",
                                "criterion": "treatability of metastatic disease",
                                "requirement": {
                                    "requirement_type": "assessment_by",
                                    "expected_value": "discretion of the treating physician"
                                }
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "3. Prior radiotherapy to the region of the study cancer that would result in overlap of radiation fields",
                "criterions": [
                    {
                        "exact_snippets": "Prior radiotherapy to the region of the study cancer that would result in overlap of radiation fields",
                        "criterion": "prior radiotherapy to the region of the study cancer",
                        "requirement": {
                            "requirement_type": "overlap of radiation fields",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Prior radiotherapy to the region of the study cancer that would result in overlap of radiation fields",
                        "criterion": "prior radiotherapy to the region of the study cancer",
                        "requirement": {
                            "requirement_type": "overlap of radiation fields",
                            "expected_value": true
                        }
                    }
                ]
            }
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [
        {
            "identified_line": {
                "line": "3. Be ≥ 18 years of age on the day of signing informed consent.",
                "criterions": [
                    {
                        "exact_snippets": "Be ≥ 18 years of age",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum age",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    },
                    {
                        "exact_snippets": "on the day of signing informed consent",
                        "criterion": "timing of age assessment",
                        "requirement": {
                            "requirement_type": "timepoint",
                            "expected_value": "on the day of signing informed consent"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Be \u0018 18 years of age",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum age",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    },
                    {
                        "exact_snippets": "on the day of signing informed consent",
                        "criterion": "timing of age assessment",
                        "requirement": {
                            "requirement_type": "timepoint",
                            "expected_value": "on the day of signing informed consent"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "3. If Gleason Grade 2, must meet definition of unfavorable intermediate risk (at least one of the following: cT2b, PSA >10 ng/mL prior to starting androgen deprivation therapy (ADT).",
                "criterions": [
                    {
                        "exact_snippets": "Gleason Grade 2",
                        "criterion": "Gleason grade",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": "=",
                                "value": 2,
                                "unit": "N/A"
                            }
                        }
                    },
                    {
                        "exact_snippets": "must meet definition of unfavorable intermediate risk (at least one of the following: cT2b, PSA >10 ng/mL prior to starting androgen deprivation therapy (ADT)",
                        "criterion": "unfavorable intermediate risk",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "cT2b",
                        "criterion": "clinical tumor stage (cT)",
                        "requirement": {
                            "requirement_type": "stage",
                            "expected_value": "T2b"
                        }
                    },
                    {
                        "exact_snippets": "PSA >10 ng/mL prior to starting androgen deprivation therapy (ADT)",
                        "criterion": "prostate-specific antigen (PSA) level",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">",
                                "value": 10,
                                "unit": "ng/mL"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "condition": {
                    "exact_snippets": "Gleason Grade 2",
                    "criterion": "Gleason grade",
                    "requirement": {
                        "requirement_type": "value",
                        "expected_value": {
                            "operator": "=",
                            "value": 2,
                            "unit": "N/A"
                        }
                    }
                },
                "then_criteria": {
                    "or_criteria": [
                        {
                            "exact_snippets": "cT2b",
                            "criterion": "clinical tumor stage (cT)",
                            "requirement": {
                                "requirement_type": "stage",
                                "expected_value": "T2b"
                            }
                        },
                        {
                            "exact_snippets": "PSA >10 ng/mL prior to starting androgen deprivation therapy (ADT)",
                            "criterion": "prostate-specific antigen (PSA) level",
                            "requirement": {
                                "requirement_type": "value",
                                "expected_value": {
                                    "operator": ">",
                                    "value": 10,
                                    "unit": "ng/mL"
                                }
                            }
                        }
                    ]
                },
                "else_criteria": null
            }
        },
        {
            "identified_line": {
                "line": "1. Pathologically (histologically or cytologically) proven diagnosis of adenocarcinoma of prostate within one year of study entry. Evaluation can happen outside of MD Anderson as long as histological confirmation takes place at MD Anderson.",
                "criterions": [
                    {
                        "exact_snippets": "Pathologically (histologically or cytologically) proven diagnosis of adenocarcinoma of prostate",
                        "criterion": "adenocarcinoma of prostate diagnosis",
                        "requirement": {
                            "requirement_type": "diagnosis_method",
                            "expected_value": [
                                "histologically",
                                "cytologically"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "Pathologically (histologically or cytologically) proven diagnosis of adenocarcinoma of prostate",
                        "criterion": "adenocarcinoma of prostate diagnosis",
                        "requirement": {
                            "requirement_type": "confirmation",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "within one year of study entry",
                        "criterion": "time since diagnosis",
                        "requirement": {
                            "requirement_type": "time_since_diagnosis",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1,
                                "unit": "year"
                            }
                        }
                    },
                    {
                        "exact_snippets": "histological confirmation takes place at MD Anderson",
                        "criterion": "histological confirmation at MD Anderson",
                        "requirement": {
                            "requirement_type": "location",
                            "expected_value": "MD Anderson"
                        }
                    },
                    {
                        "exact_snippets": "histological confirmation takes place at MD Anderson",
                        "criterion": "histological confirmation at MD Anderson",
                        "requirement": {
                            "requirement_type": "confirmation",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        }
    ],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}